Oral delivery a possibility for silica-based nanocarriers for therapeutics

Take a pill, or get a shot? Given the choice, most people would likely go for the former.

Ultrasmall fluorescent core-shell hybrid silica nanoparticles—known as Cornell Prime Dots, or C’Dots—are among the nanocarriers for therapeutics that were thought to be viable only by injection, but new Cornell research has shown the potential for their oral…